ID3: A Potential Drug Target and Biomarker for Basic Helix-Loop-Helix Proteins

Target Name: ID3

NCBI ID: G3399

Content of Review Report on ID3 Target / Biomarker

ID3

ID3: A Potential Drug Target and Biomarker for Basic Helix-Loop-Helix Proteins

Basic helix-loop-helix (BHLH) proteins are a family of non-coding RNAs that play a crucial role in gene regulation and DNA replication. They are involved in the regulation of various cellular processes, including cell growth, differentiation, and response to environmental stimuli. ID3, a class B BHLH protein, has been identified as a potential drug target and biomarker for various diseases. In this article, we will discuss the biology of ID3 and its potential as a drug target and biomarker.

Biography of ID3

ID3 is a 198-amino acid long protein that contains a unique H1 loop and a double H2 loop. It has a calculated molecular weight of 19.1 kDa and a pI of 6.9. ID3 is expressed in various tissues and cells, including liver, lung, heart, and pancreas. It is a good candidate for a drug target due to its unique structure and its involvement in cellular processes.

ID3 Functions

ID3 plays a crucial role in gene regulation and DNA replication. It is involved in the regulation of DNA binding, transcription, and DNA replication. ID3 functions as a negative regulator of DNA replication by preventing the entry of the template DNA into the complex. It does this by interacting with the protamine N7 gene, which is located upstream of the start site of the replication complex.

ID3 is also involved in the regulation of cell growth and differentiation. It has been shown to regulate cell growth by controlling the amount of cellularushi acid produced. Additionally, ID3 has been shown to play a role in the regulation of cellular differentiation by controlling the levels of specific transcription factors.

ID3 and Diseases

ID3 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. One of the main reasons for its potential as a drug target is its involvement in the regulation of cellular processes that are altered in these diseases.

ID3 has been shown to be involved in the regulation of cancer cell growth and survival. It has been shown to inhibit the growth of various cancer cell lines in cell culture and in animal models of cancer. Additionally, ID3 has been shown to enhance the sensitivity of cancer cells to chemotherapy by inhibiting the formation of the interphase complex.

ID3 has also been shown to be involved in the regulation of neurodegenerative diseases. It has been shown to contribute to the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. ID3 has been shown to interact with the neurotransmitter dopamine and to regulate the levels of dopamine receptor function.

ID3 has also been shown to be involved in the regulation of developmental disorders. It has been shown to contribute to the development of developmental disorders, including Down syndrome and Fragile X syndrome. ID3 has been shown to interact with the transcription factor FMR1 and to regulate the levels of its target genes.

ID3 as a Biomarker

ID3 has also been shown to be a potential biomarker for various diseases. It has been shown to be involved in the regulation of cellular processes that are altered in these diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, ID3 has been shown to be a potential biomarker for these diseases.

ID3 has been shown to be involved in the regulation of cancer cell growth and survival. It has been shown to inhibit the growth of various cancer cell lines in cell culture and in animal models of cancer. Additionally, ID3 has been shown to enhance the sensitivity of cancer cells to chemotherapy by inhibiting the formation of the interphase complex.

ID3 has also been shown to be involved in the regulation of neurodegenerative diseases. It has been shown to contribute to the development of

Protein Name: Inhibitor Of DNA Binding 3

Functions: Transcriptional regulator (lacking a basic DNA binding domain) which negatively regulates the basic helix-loop-helix (bHLH) transcription factors by forming heterodimers and inhibiting their DNA binding and transcriptional activity. Implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation. Involved in myogenesis by inhibiting skeletal muscle and cardiac myocyte differentiation and promoting muscle precursor cells proliferation. Inhibits the binding of E2A-containing protein complexes to muscle creatine kinase E-box enhancer. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer

The "ID3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ID3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets